Broncho-munal

For treatment of: treatment of acute respiratory infections of the upper respiratory tract

Broncho-munal

For the treatment of internal organs: Broncho-munal treatment of acute respiratory infections of the upper respiratory tract
Purpose: respiratory system
Appointment: treatment of acute respiratory infections of the upper respiratory tract
Indications for use:
The drug is used from the age of 12 for:
- prevention of recurrent respiratory tract infection and exacerbations of chronic bronchitis;
- complex treatment of acute respiratory tract infections.
Contraindications:
- Hypersensitivity to the active component or to any of the auxiliary components of the drug;
- pregnancy, breast-feeding period.
Composition:
Active substance: lyophilized lysates of bacteria: Haemophilus influenzae, Streptococcus pneumoniae, Streptococcus viridans, Streptococcus pyogenes, Klebsiella pneumoniae, Klebsiella ozaenae, Staphylococcus aureus, Moraxella catarrhalis – 7 mg
Excipients: propyl gallate (anhydrous) – 0.084 mg, sodium glutamate anhydrous – 3.03 mg, mannitol – up to 40 mg, magnesium stearate – 3 mg, pre-gelatinized starch – 110 mg, mannitol – up to 200 mg. Capsule shell: indigocarmine - 0.03 mg, titanium dioxide - 1.00 mg, gelatin - up to 50.00 mg.
Manufacturer: Sandoz